Targeting Glioblastoma Stem Cells via EphA2: Structural Insights into the RNA Aptamer A40s for Precision Therapy
Journal of Chemical Information and Modeling · 2025
DOI: 10.1021/acs.jcim.5c00295 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Chemical Information and Modeling, 2025. Verfasst von Isidora Diakogiannaki und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, University of Naples Federico II, Via Domenico Montesano 49, 80131 Naples, Italy. Hauptthemen laut MEDLINE: Aptamers, Nucleotide, Neoplastic Stem Cells, Glioblastoma, Receptor, EphA2. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 95 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministero dell'Universit? e della Ricerca, NextGenerationEU.
Abstract (Originalsprache)
EphA2 receptor tyrosine kinase is overexpressed in many solid tumors and serves as a key driver of tumorigenesis and metastasis. It is highly expressed in glioblastoma multiforme, the most aggressive brain tumor in adults, and in its stem cells [glioblastoma stem cells (GSCs)], which contribute to treatment resistance and tumor relapse. In a previous study, we used the Systematic Evolution of Ligands by Exponential Enrichment (SELEX) procedure, a method for selecting high-affinity nucleic acids to specific targets via iterative selection and amplification, to identify the 2'-fluorinated EphA2-targeting RNA aptamer A40L and a truncated 30-mer derivative, A40s. Both aptamers were able to inhibit GSC growth, stemness, and migration upon EphA2 binding. Here, by integrating computational and experimental methods, the A40s structure was unraveled and its interaction with EphA2 was investigated. Our model offers a blueprint to accelerate the development of optimized A40s variants, advancing next-generation EphA2-targeted anticancer therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, University of Naples Federico II, Via Domenico Montesano 49, 80131 Naples, Italy.
- Department of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, Via Sergio Pansini 5, 80131 Naples, Italy.
- Institute of Experimental Institute of Endotypes in Oncology, Metabolism and Immunology "G. Salvatore" (IEOMI), Consiglio Nazionale delle Ricerche (CNR), 80131 Naples, Italy.
- Institute for Biochemistry, Leipzig University, Brüderstraße 34, 04103 Leipzig, Germany.
ORCID-Profile: Alessandra Affinito, Mario Mörl, Francesco Saverio Di Leva, Luciana Marinelli
Förderung
- Ministero dell'Universit? e della Ricerca
- NextGenerationEU
Zitieren
APA
Diakogiannaki, I., D'Amore, V. M., Affinito, A., Donati, G., Cinquegrana, E., Quintavalle, C., Mascolo, M., Walter, J., Betat, H., Mörl, M., Di Leva, F. S., Condorelli, G., & Marinelli, L. (2025). Targeting Glioblastoma Stem Cells via EphA2: Structural Insights into the RNA Aptamer A40s for Precision Therapy. Journal of Chemical Information and Modeling. https://doi.org/10.1021/acs.jcim.5c00295
Vancouver
Diakogiannaki I, D'Amore VM, Affinito A, Donati G, Cinquegrana E, Quintavalle C, et al. Targeting Glioblastoma Stem Cells via EphA2: Structural Insights into the RNA Aptamer A40s for Precision Therapy. Journal of Chemical Information and Modeling. 2025. doi:10.1021/acs.jcim.5c00295
BibTeX
@article{Diakogiannaki2025,
author = {Diakogiannaki, Isidora and D'Amore, Vincenzo Maria and Affinito, Alessandra and Donati, Greta and Cinquegrana, Elpidio and Quintavalle, Cristina and Mascolo, Martina and Walter, Jule and Betat, Heike and Mörl, Mario and Di Leva, Francesco Saverio and Condorelli, Gerolama and Marinelli, Luciana},
title = {Targeting Glioblastoma Stem Cells via EphA2: Structural Insights into the RNA Aptamer A40s for Precision Therapy},
journal = {Journal of Chemical Information and Modeling},
year = {2025},
doi = {10.1021/acs.jcim.5c00295}
}
EUVIMED